Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page
- Check3 days agoChange DetectedA new Revision: v3.7.0 tag appears, and a large set of study-related sections and personnel/location details are removed, changing how the study record is presented.SummaryDifference20%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6, indicating a minor revision to the page. It does not appear to alter core study details.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page shows an updated revision tag, changing from v3.6.4 to v3.6.5. This indicates a small documentation update rather than a substantive content change.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a backend/template update that does not change the visible study details.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing v3.6.2, indicating a new version of the referenced protocol/documentation. This is a technical update to the page's supporting materials and does not change the study details presented.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a minor release of the page template/backend rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.